Floatz logo

Apixaban

Ascites

Asian Institute Of Medical SciencesSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Ascites cohort.

Asset / SponsorPhaseRating
Tolvaptan
Konkuk University Medical Center
Phase 4BBB
NORMAL HUMAN SERUM ALBUMIN
Centro Medico Issemym
Phase 4BBB
FUROSEMIDE
University of Palermo
Phase 4BB
Rifaximin
Centre Hospitalier Universitaire de Besancon
Phase 4BB
Spironolactone
University of Padova
Phase 4BB

View all 36 →

Same molecule, other indications

Apixaban is also rated in:

venous thromboembolismDormant
BBB
Indicative ·
79 / 100
View asset →
venous thromboembolismDormant
BBB
Indicative ·
79 / 100
View asset →
atrial fibrillationDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →